Merck’s Newly Approved Capvaxive Could Have Edge Over Prevnar 20 In Adults

 
• By Jessica Merrill
pneumococcal vaccine
Merck & Co.'s 21-valent pneumococcal vaccine was approved by FDA • Source: Shutterstock

More from New Products

More from Scrip